Cargando…

Safe Administration of Cemiplimab to a Kidney Transplant Patient with Locally Advanced Squamous Cell Carcinoma of the Scalp

Immunotherapies directed at T-cell activation through antibodies targeting checkpoint proteins, such as programmed cell death 1 (PD1), are rapidly becoming the new standard of care in the treatment of several malignancies. Cemiplimab is a monoclonal antibody targeting PD1 that has recently emerged a...

Descripción completa

Detalles Bibliográficos
Autores principales: Paoluzzi, Luca, Ow, Thomas J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903284/
https://www.ncbi.nlm.nih.gov/pubmed/33477979
http://dx.doi.org/10.3390/curroncol28010057